Docquity and Novartis partner to improve retinal health education and care standards for healthcare professionals and patients in Malaysia.
This partnership between Docquity and Novartis highlights a focused effort to tackle a specific health issue, retinal diseases, in Malaysia. By combining Novartis's pharmaceutical expertise with Docquity's digital reach, they can significantly improve awareness and education among healthcare providers and patients. This could lead to earlier diagnosis and better management of retinal conditions, impacting public health outcomes in Malaysia and potentially serving as a model for other regions.
This partnership is specifically focused on Malaysia, addressing a critical health concern within the Southeast Asian region.
Focus is on early detection and management of retinal conditions.
The initiative seeks to improve the standard of care for eye diseases.
Docquity and Novartis are partnering to address retinal health in Malaysia.
The collaboration aims to educate healthcare professionals and patients.
Focus is on early detection and management of retinal conditions.
Docquity has entered into a partnership with Novartis to address retinal health challenges in Malaysia. This collaboration will leverage Docquity's platform to educate healthcare professionals and patients about various retinal conditions, their early detection, and management. The initiative aims to improve the standard of care for eye diseases in the region.
Sign in to save notes on signals.
Sign In